Status:
NOT_YET_RECRUITING
Faisability and Efficacity of the Reinforced Communautary Support Program (PARC) on the Complications of Chemsex
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Chemsex
Addiction
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The complications associated with chemsex concern infectious disease specialists, addiction specialists, and public authorities. Chemsex is defined among men who have sex with men (MSM) and trans and ...
Detailed Description
At 190, a community sexual health center in Paris, more than one in five patients engage in chemsex. The complications associated with chemsex concern infectious disease specialists, addiction special...
Eligibility Criteria
Inclusion
- MSM and/or non-binary individuals, trans men or women associated with gay sexual networks
- Engaging in chemsex (as defined by the European Chemsex Forum and having consumed at least twice a cathinone and/or methamphetamine and/or GHB/GBL)
- Seeking care for chemsex
- Referred to the PARC program with the goal of reducing or stopping consumption
- Not opposed to data collection for this study
- Uncontrolled somatic or psychiatric conditions
Exclusion
- Refusal to participate
Key Trial Info
Start Date :
September 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06610916
Start Date
September 20 2024
End Date
September 20 2026
Last Update
September 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Le 190 - Centre de Santé Sexuelle / CeGIDD
Paris, France, 75011